Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8TZC

Structure of C-terminal LRRK2 bound to MLi-2 (G2019S mutant)

8TZC の概要
エントリーDOI10.2210/pdb8tzc/pdb
関連するPDBエントリー8TXZ
EMDBエントリー41754
分子名称Leucine-rich repeat serine/threonine-protein kinase 2, E11 DARPin, (2~{R},6~{S})-2,6-dimethyl-4-[6-[5-(1-methylcyclopropyl)oxy-1~{H}-indazol-3-yl]pyrimidin-4-yl]morpholine, ... (5 entities in total)
機能のキーワードgtpase, kinase, inhibitors, protein binding
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計156794.37
構造登録者
Sanz-Murillo, M.,Villagran-Suarez, A.,Alegrio-Louro, J.,Leschziner, A. (登録日: 2023-08-26, 公開日: 2023-12-06, 最終更新日: 2024-10-23)
主引用文献Sanz Murillo, M.,Villagran Suarez, A.,Dederer, V.,Chatterjee, D.,Alegrio Louro, J.,Knapp, S.,Mathea, S.,Leschziner, A.E.
Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures.
Sci Adv, 9:eadk6191-eadk6191, 2023
Cited by
PubMed Abstract: Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common cause of familial Parkinson's disease (PD) and a risk factor for the sporadic form. Increased kinase activity was shown in patients with both familial and sporadic PD, making LRRK2 kinase inhibitors a major focus of drug development efforts. Although much progress has been made in understanding the structural biology of LRRK2, there are no available structures of LRRK2 inhibitor complexes. To this end, we solved cryo-electron microscopy structures of LRRK2, wild-type and PD-linked mutants, bound to the LRRK2-specific type I inhibitor MLi-2 and the broad-spectrum type II inhibitor GZD-824. Our structures revealed an active-like LRRK2 kinase in the type I inhibitor complex, and an inactive DYG-out in the type II inhibitor complex. Our structural analysis also showed how inhibitor-induced conformational changes in LRRK2 are affected by its autoinhibitory N-terminal repeats. The structures provide a template for the rational development of LRRK2 kinase inhibitors covering both canonical inhibitor binding modes.
PubMed: 38039358
DOI: 10.1126/sciadv.adk6191
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.7 Å)
構造検証レポート
Validation report summary of 8tzc
検証レポート(詳細版)ダウンロードをダウンロード

238268

件を2025-07-02に公開中

PDB statisticsPDBj update infoContact PDBjnumon